Development of peptide inhibitors of HIV transmission

Document Type

Article

Publication Date

12-1-2016

Abstract

Treatment of HIV has long faced the challenge of high mutation rates leading to rapid development of resistance, with ongoing need to develop new methods to effectively fight the infection. Traditionally, early HIV medications were designed to inhibit RNA replication and protein production through small molecular drugs. Peptide based therapeutics are a versatile, promising field in HIV therapy, which continues to develop as we expand our understanding of key protein-protein interactions that occur in HIV replication and infection. This review begins with an introduction to HIV, followed by the biological basis of disease, current clinical management of the disease, therapeutics on the market, and finally potential avenues for improved drug development.

Identifier

85049001114 (Scopus)

Publication Title

Bioactive Materials

External Full Text Location

https://doi.org/10.1016/j.bioactmat.2016.09.004

ISSN

2452199X

First Page

109

Last Page

121

Issue

2

Volume

1

This document is currently not available here.

Share

COinS